Information Provided By:
Fly News Breaks for August 27, 2018
TRUMY, MMSI
Aug 27, 2018 | 07:17 EDT
SunTrust analyst Bruce Nudell raised his price target on Merit Medical (MMSI) to $68 and kept his Buy rating, saying he is updating his model based on the company's execution of a "sound strategy". The analyst is positive on Merit Medical's "continual incremental innovation in its more commoditized product segments coupled with a gradual movement into higher margin therapeutic areas". Nudell also expects the company to benefit from hospitals looking to diversify away from single sourcing of products after a recent supply-shortage related shipment halt from Terumo (TRUMY).
News For MMSI;TRUMY From the Last 2 Days
There are no results for your query MMSI;TRUMY